首页> 外文OA文献 >In vivo assessment of bifurcation optimal viewing angles and bifurcation angles by three-dimensional (3D) quantitative coronary angiography
【2h】

In vivo assessment of bifurcation optimal viewing angles and bifurcation angles by three-dimensional (3D) quantitative coronary angiography

机译:通过三维(3D)定量冠状动脉造影术对分叉的最佳视角和分叉角度进行体内评估

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Evaluation and stenting of coronary bifurcation lesions may benefit from optimal angiographic views. The anatomy-defined bifurcation optimal viewing angle (ABOVA) is characterized by having an orthogonal view of the bifurcation, such that overlap and foreshortening at the ostium are minimized. However, due to the mechanical constraints of the X-ray systems, certain deep angles cannot be reached by the C-arm. Therefore, second best or, so-called obtainable bifurcation optimal viewing angle (OBOVA) has to be used as an alternative. This study assessed the distributions of ABOVA and OBOVA using 3D quantitative coronary angiography in a typical patient population. In addition, the bifurcation angles in four main coronary bifurcations were assessed and compared. Patients with obstructive coronary bifurcation disease were included in this multicenter registry. A novel and validated 3D QCA software package was applied to reconstruct the bifurcations and to calculate the bifurcation angles in 3D. A list of optimal viewing angle candidates including ABOVA was also automatically proposed by the software. In a next step, the operator selected the best viewing angle as OBOVA, while applying a novel overlap prediction approach to assure no overlap between the target bifurcation and other major coronary arteries. A total of 194 bifurcations from 181 patients were assessed. The ABOVA could not be reached in 56.7% of the cases; being 40 (81.6%), 40 (78.4%), 9 (17.6%), and 21 (48.8%) cases for LM/LAD/LCx, LAD/Diagonal, LCx/OM, and PDA/PLA, respectively. Both ABOVA and OBOVA distributed sparsely with large ranges of variance: LM/LAD/LCx, 5 ± 33 RAO, 47 ± 35 Caudal versus 4 ± 39 LAO, 35 ± 16 Caudal; LAD/Diagonal, 4 ± 38 RAO, 50 ± 14 Cranial versus 14 ± 28 LAO, 33 ± 5 Cranial; LCx/OM, 21 ± 32 LAO, 27 ± 17 Caudal versus 18 ± 31 LAO, 25 ± 13 Caudal; PDA/PLA, 34 ± 21 LAO, 36 ± 21 Cranial versus 28 ± 25 LAO, 29 ± 15 Cranial. LM/LAD/LCx had the smallest proximal bifurcation angle (128° ± 24°) and the largest distal bifurcation angle (80° ± 21°), as compared with LAD/Diagonal (151° ± 13º and 48° ± 16º), LCx/OM (146° ± 18º and 57° ± 16°), and PDA/PLA (145° ± 19° and 59° ± 17°). In conclusion, large variabilities in optimal viewing angles existed for all main coronary bifurcations. The anatomy-defined bifurcation optimal viewing angle could not be reached in vivo in roughly half of the cases due to the mechanical constraints of the current X-ray systems. Obtainable bifurcation optimal viewing angle should be provided as an alternative or second best. The bifurcation angles in the left main bifurcation demonstrated the largest variabilities.
机译:冠状动脉分叉病变的评估和支架置入可能受益于最佳的血管造影视图。解剖学定义的分叉最佳视角(ABOVA)的特征是具有分叉的正交视图,从而使孔口的重叠和缩短最小化。但是,由于X射线系统的机械限制,C形臂无法达到某些深角度。因此,必须使用次优或所谓的可获得的分叉最优视角(OBOVA)。这项研究使用3D定量冠状动脉造影术评估了典型患者人群中ABOVA和OBOVA的分布。此外,评估并比较了四个主要冠状动脉分叉处的分叉角。阻塞性冠状动脉分叉疾病患者包括在该多中心登记中。应用新颖且经过验证的3D QCA软件包重建分叉并计算3D中的分叉角度。该软件还自动提出了包括ABOVA在内的最佳视角候选者列表。下一步,操作员选择最佳视角作为OBOVA,同时应用新颖的重叠预测方法来确保目标分叉和其他主要冠状动脉之间没有重叠。评估了来自181例患者的194个分支。 56.7%的案例无法达到ABOVA; LM / LAD / LCx,LAD /对角线,LCx / OM和PDA / PLA分别为40(81.6%),40(78.4%),9(17.6%)和21(48.8%)例。 ABOVA和OBOVA都稀疏分布,且变化范围较大:LM / LAD / LCx,5±33 RAO,47±35尾与4±39 LAO,35±16尾; LAD /对角线,4±38 RAO,50±14颅骨vs 14±28 LAO,33±5颅骨; LCx / OM,21±32 LAO,27±17尾与18±31 LAO,25±13尾; PDA / PLA,34±21 LAO,36±21颅骨与28±25 LAO,29±15颅骨。与LAD /对角线(151°±13º和48°±16º)相比,LM / LAD / LCx具有最小的近端分叉角(128°±24°)和最大的远端分叉角(80°±21°), LCx / OM(146°±18°和57°±16°)和PDA / PLA(145°±19°和59°±17°)。总之,所有主要冠状动脉分叉的最佳视角均存在较大差异。由于当前X射线系统的机械限制,在大约一半的情况下无法在体内达到解剖学定义的最佳分叉角度。作为替代方案或次优方案,应提供可获得的分叉最佳视角。左主分叉处的分叉角显示出最大的变化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号